ArticleHaematologica2022

Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients.

Jennifer R Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.